SPL 2.11% 9.3¢ starpharma holdings limited

Ann: Quarterly Cashflow Report, page-2

  1. 10,009 Posts.
    lightbulb Created with Sketch. 219
    I like the DEP news,as that's were the big news/money is waiting to hear from...

    page 2

    based on POSITIVE feedback from Oncologists involved docetaxcal- nintedanid lung cancer study ..

    SPL is planning to Expand recruitment in this combination arm study...And NO HAIR LOSS has

    been reported,the allan kholer Qantas interview was a big wow .. NO HAIR LOSS for cancer

    patients.

    Atrazenca program...further compounds advanced !!! small sentence,Big meaning for SPL !!!

    enjoy the newsflow holders,i,m comfortable and buying more.company has plenty of cash,and growing too
    Last edited by koro: 17/07/18
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.